IBDEI0SN ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12892,1,3,0)
 ;;=3^Exudative Retinopathy,OD
 ;;^UTILITY(U,$J,358.3,12892,1,4,0)
 ;;=4^H35.021
 ;;^UTILITY(U,$J,358.3,12892,2)
 ;;=^5005586
 ;;^UTILITY(U,$J,358.3,12893,0)
 ;;=H35.022^^51^623^42
 ;;^UTILITY(U,$J,358.3,12893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12893,1,3,0)
 ;;=3^Exudative Retinopathy,OS
 ;;^UTILITY(U,$J,358.3,12893,1,4,0)
 ;;=4^H35.022
 ;;^UTILITY(U,$J,358.3,12893,2)
 ;;=^5005587
 ;;^UTILITY(U,$J,358.3,12894,0)
 ;;=H35.09^^51^623^37
 ;;^UTILITY(U,$J,358.3,12894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12894,1,3,0)
 ;;=3^Intraretinal Microvascular Abnormalities,Other
 ;;^UTILITY(U,$J,358.3,12894,1,4,0)
 ;;=4^H35.09
 ;;^UTILITY(U,$J,358.3,12894,2)
 ;;=^268617
 ;;^UTILITY(U,$J,358.3,12895,0)
 ;;=H35.23^^51^623^46
 ;;^UTILITY(U,$J,358.3,12895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12895,1,3,0)
 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OU
 ;;^UTILITY(U,$J,358.3,12895,1,4,0)
 ;;=4^H35.23
 ;;^UTILITY(U,$J,358.3,12895,2)
 ;;=^5005645
 ;;^UTILITY(U,$J,358.3,12896,0)
 ;;=H35.21^^51^623^44
 ;;^UTILITY(U,$J,358.3,12896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12896,1,3,0)
 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OD
 ;;^UTILITY(U,$J,358.3,12896,1,4,0)
 ;;=4^H35.21
 ;;^UTILITY(U,$J,358.3,12896,2)
 ;;=^5005643
 ;;^UTILITY(U,$J,358.3,12897,0)
 ;;=H35.22^^51^623^45
 ;;^UTILITY(U,$J,358.3,12897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12897,1,3,0)
 ;;=3^Non-Diabetic Proliferative Retinopathy,Other,OS
 ;;^UTILITY(U,$J,358.3,12897,1,4,0)
 ;;=4^H35.22
 ;;^UTILITY(U,$J,358.3,12897,2)
 ;;=^5005644
 ;;^UTILITY(U,$J,358.3,12898,0)
 ;;=H35.043^^51^623^30
 ;;^UTILITY(U,$J,358.3,12898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12898,1,3,0)
 ;;=3^Retinal Micro-Aneurysms,Unspec,OU
 ;;^UTILITY(U,$J,358.3,12898,1,4,0)
 ;;=4^H35.043
 ;;^UTILITY(U,$J,358.3,12898,2)
 ;;=^5005596
 ;;^UTILITY(U,$J,358.3,12899,0)
 ;;=H35.041^^51^623^28
 ;;^UTILITY(U,$J,358.3,12899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12899,1,3,0)
 ;;=3^Retinal Micro-Aneurysms,Unspec,OD
 ;;^UTILITY(U,$J,358.3,12899,1,4,0)
 ;;=4^H35.041
 ;;^UTILITY(U,$J,358.3,12899,2)
 ;;=^5005594
 ;;^UTILITY(U,$J,358.3,12900,0)
 ;;=H35.042^^51^623^29
 ;;^UTILITY(U,$J,358.3,12900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12900,1,3,0)
 ;;=3^Retinal Micro-Aneurysms,Unspec,OS
 ;;^UTILITY(U,$J,358.3,12900,1,4,0)
 ;;=4^H35.042
 ;;^UTILITY(U,$J,358.3,12900,2)
 ;;=^5005595
 ;;^UTILITY(U,$J,358.3,12901,0)
 ;;=H35.053^^51^623^33
 ;;^UTILITY(U,$J,358.3,12901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12901,1,3,0)
 ;;=3^Retinal Neovascularization,Unspec,OU
 ;;^UTILITY(U,$J,358.3,12901,1,4,0)
 ;;=4^H35.053
 ;;^UTILITY(U,$J,358.3,12901,2)
 ;;=^5005600
 ;;^UTILITY(U,$J,358.3,12902,0)
 ;;=H35.051^^51^623^31
 ;;^UTILITY(U,$J,358.3,12902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12902,1,3,0)
 ;;=3^Retinal Neovascularization,Unspec,OD
 ;;^UTILITY(U,$J,358.3,12902,1,4,0)
 ;;=4^H35.051
 ;;^UTILITY(U,$J,358.3,12902,2)
 ;;=^5005598
 ;;^UTILITY(U,$J,358.3,12903,0)
 ;;=H35.052^^51^623^32
 ;;^UTILITY(U,$J,358.3,12903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12903,1,3,0)
 ;;=3^Retinal Neovascularization,Unspec,OS
 ;;^UTILITY(U,$J,358.3,12903,1,4,0)
 ;;=4^H35.052
 ;;^UTILITY(U,$J,358.3,12903,2)
 ;;=^5005599
 ;;^UTILITY(U,$J,358.3,12904,0)
 ;;=H35.073^^51^623^36
 ;;^UTILITY(U,$J,358.3,12904,1,0)
 ;;=^358.31IA^4^2
